Kataja V - Search Results

1

NAT2 slow acetylator genotype as an important modifier of breast cancer risk.

Sillanpää P, Hirvonen A, Kataja V, Eskelinen M, Kosma VM, Uusitupa M, Vainio H, Mitrunen K. Sillanpää P, et al. Among authors: kataja v. Int J Cancer. 2005 Apr 20;114(4):579-84. doi: 10.1002/ijc.20677. Int J Cancer. 2005. PMID: 15609332

2

Steroid metabolism gene CYP17 polymorphism and the development of breast cancer.

Mitrunen K, Jourenkova N, Kataja V, Eskelinen M, Kosma VM, Benhamou S, Vainio H, Uusitupa M, Hirvonen A. Mitrunen K, et al. Among authors: kataja v. Cancer Epidemiol Biomarkers Prev. 2000 Dec;9(12):1343-8. Cancer Epidemiol Biomarkers Prev. 2000. PMID: 11142420

3

Glutathione S-transferase M1, M3, P1, and T1 genetic polymorphisms and susceptibility to breast cancer.

Mitrunen K, Jourenkova N, Kataja V, Eskelinen M, Kosma VM, Benhamou S, Vainio H, Uusitupa M, Hirvonen A. Mitrunen K, et al. Among authors: kataja v. Cancer Epidemiol Biomarkers Prev. 2001 Mar;10(3):229-36. Cancer Epidemiol Biomarkers Prev. 2001. PMID: 11303592

4

Association between manganese superoxide dismutase (MnSOD) gene polymorphism and breast cancer risk.

Mitrunen K, Sillanpää P, Kataja V, Eskelinen M, Kosma VM, Benhamou S, Uusitupa M, Hirvonen A. Mitrunen K, et al. Among authors: kataja v. Carcinogenesis. 2001 May;22(5):827-9. doi: 10.1093/carcin/22.5.827. Carcinogenesis. 2001. PMID: 11323405

5

Polymorphic catechol-O-methyltransferase gene and breast cancer risk.

Mitrunen K, Jourenkova N, Kataja V, Eskelinen M, Kosma VM, Benhamou S, Kang D, Vainio H, Uusitupa M, Hirvonen A. Mitrunen K, et al. Among authors: kataja v. Cancer Epidemiol Biomarkers Prev. 2001 Jun;10(6):635-40. Cancer Epidemiol Biomarkers Prev. 2001. PMID: 11401913

6

Combined COMT and GST genotypes and hormone replacement therapy associated breast cancer risk.

Mitrunen K, Kataja V, Eskelinen M, Kosma VM, Kang D, Benhamou S, Vainio H, Uusitupa M, Hirvonen A. Mitrunen K, et al. Among authors: kataja v. Pharmacogenetics. 2002 Jan;12(1):67-72. doi: 10.1097/00008571-200201000-00009. Pharmacogenetics. 2002. PMID: 11773866

7

Vitamin D receptor gene polymorphism as an important modifier of positive family history related breast cancer risk.

Sillanpää P, Hirvonen A, Kataja V, Eskelinen M, Kosma VM, Uusitupa M, Vainio H, Mitrunen K. Sillanpää P, et al. Among authors: kataja v. Pharmacogenetics. 2004 Apr;14(4):239-45. doi: 10.1097/00008571-200404000-00003. Pharmacogenetics. 2004. PMID: 15083068

8

Sulfotransferase 1A1 genotype as a potential modifier of breast cancer risk among premenopausal women.

Sillanpää P, Kataja V, Eskelinen M, Kosma VM, Uusitupa M, Vainio H, Mitrunen K, Hirvonen A. Sillanpää P, et al. Among authors: kataja v. Pharmacogenet Genomics. 2005 Oct;15(10):749-52. doi: 10.1097/01.fpc.0000172240.34923.46. Pharmacogenet Genomics. 2005. PMID: 16141802

9

XRCC1 and XPD genetic polymorphisms, smoking and breast cancer risk in a Finnish case-control study.

Metsola K, Kataja V, Sillanpää P, Siivola P, Heikinheimo L, Eskelinen M, Kosma VM, Uusitupa M, Hirvonen A. Metsola K, et al. Among authors: kataja v. Breast Cancer Res. 2005;7(6):R987-97. doi: 10.1186/bcr1333. Epub 2005 Oct 11. Breast Cancer Res. 2005. PMID: 16280050 Free PMC article.

10

Refinement of the 22q12-q13 breast cancer--associated region: evidence of TMPRSS6 as a candidate gene in an eastern Finnish population.

Hartikainen JM, Tuhkanen H, Kataja V, Eskelinen M, Uusitupa M, Kosma VM, Mannermaa A. Hartikainen JM, et al. Among authors: kataja v. Clin Cancer Res. 2006 Mar 1;12(5):1454-62. doi: 10.1158/1078-0432.CCR-05-1417. Clin Cancer Res. 2006. PMID: 16533768

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

227 results

Search Page

Filters